Adicet Bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Adicet Bio and other ETFs, options, and stocks.About ACET
Adicet Bio, Inc. is a clinical stage biotechnology company, which engages in discovering and developing allogeneic gamma delta T cell therapies for cancer. It also focuses on developing a pipeline of “off-the-shelf” gamma delta T cells.
CEOChen Schor
CEOChen Schor
Employees152
Employees152
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2014
Founded2014
Employees152
Employees152
ACET Key Statistics
Market cap102.30M
Market cap102.30M
Price-Earnings ratio-0.52
Price-Earnings ratio-0.52
Dividend yield—
Dividend yield—
Average volume1.89M
Average volume1.89M
High today$0.6956
High today$0.6956
Low today$0.6412
Low today$0.6412
Open price$0.65
Open price$0.65
Volume868.37K
Volume868.37K
52 Week high$1.19
52 Week high$1.19
52 Week low$0.4471
52 Week low$0.4471
Stock Snapshot
As of today, Adicet Bio(ACET) shares are valued at $0.66. The company's market cap stands at 102.3M, with a P/E ratio of -0.52.
During the trading session on 2025-11-14, Adicet Bio(ACET) shares reached a daily high of $0.70 and a low of $0.64. At a current price of $0.66, the stock is +3.1% higher than the low and still -5.0% under the high.
Trading activity shows a volume of 868.37K, compared to an average daily volume of 1.89M.
The stock's 52-week range extends from a low of $0.45 to a high of $1.19.
The stock's 52-week range extends from a low of $0.45 to a high of $1.19.
Analyst ratings
88%
of 8 ratingsBuy
87.5%
Hold
12.5%
Sell
0%
People also own
Based on the portfolios of people who own ACET. This list is generated using Robinhood data, and it’s not a recommendation.